Headlines

BioMedNewsBreaks

BioMedNewsBreaks — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Highlights Two Years of Clinical Milestones Across Oncology and Rare Disease Programs 
Oncotelic Therapeutics, Inc. (OTLC)
September 12, 2025
BioMedNewsBreaks – HealthLynked Corp. (OTCQB: HLYK) Expands IP Portfolio with New U.S. Patent Filings
HealthLynked Corp. (HLYK)
September 12, 2025
BioMedNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Featured in MarketScreener Editorial on Targeted AI Applications
Izotropic Corp. (IZOZF)
September 11, 2025
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Reports 51% Revenue Growth, Strong Cash Position to Advance AVERSA Fentanyl
Nutriband Inc. (NTRB)
September 10, 2025
BioMedNewsBreaks — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Engages IBN to Lead Corporate Communications
Oncotelic Therapeutics, Inc. (OTLC)
September 10, 2025
View More BioMedNewsBreaks

BioMedWire Articles

Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF): When 15 Years of Data Creates Unassailable AI Advantage
Izotropic Corp. (IZOZF)
September 12, 2025
HeartBeam Inc. (NASDAQ: BEAT) Prepares Innovative ECG Technology for Commercial Launch
HeartBeam Inc. (BEAT)
September 12, 2025
Study Finds That Common Sweetener Could Compromise Cancer Treatment Effectiveness
Calidi Biotherapeutics Inc. (CLDI)
September 12, 2025
Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF): Exclusive CADx Patent Positions IzoView as First-Mover in AI-Enhanced Breast CT
Izotropic Corp. (IZOZF)
September 11, 2025
Adageis Simplifies Value-Based Care with AI Platform Focused on Financial Gain, Increased Visibility
Adageis
September 11, 2025
View All BioMedWire Articles

Public Press Releases

Filter Releases
Filters
Sector



Remove All Filters
Symbol Release Time Source
{{ release.qmtopics.qmsymbol[0].symbol }} {{ release.headline }} {{ release.datetime | amDateFormat:'hh:mm A'}} {{ release.source }}
Load More

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000

BioMedWire
BioMedWire

1108 Lavaca St
Suite 110-BMW
Austin, TX 78701
(512) 354-7000

Company Search
Get Quote
Site Search

Copyright © . BioMedWire / 1108 Lavaca St Suite 110-BMW Austin, TX 78701 (512) 354-7000 / Disclaimers